MUKKA — Mukka Proteins Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapTurnaround

Annual income statement for Mukka Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	—	11,771	13,798	10,064	14,495
Cost of Revenue
Gross Profit	—	2,198	2,231	2,155	2,801
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,420	10,946	12,858	9,243	13,508
Operating Profit	—	825	940	821	986
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	360	659	875	603	751
Provision for Income Taxes
Net Income After Taxes	—	475	743	481	571
Minority Interest
Net Income Before Extraordinary Items
Net Income	—	441	701	465	521
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	—	441	701	465	521
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	—	1.44	2.32	1.55	1.74
Dividends per Share